Stellenwert der renalen Sympathikusdenervation in der Hypertonietherapie und darüber hinaus – Erfahrungen aus Berlin

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal für Klinische Endokrinologie und Stoffwechsel - Austrian Journal of Clinical Endocrinology and Metabolism

• Publication date

  2014-05-22

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety

  2014cited by this paper
• PERIPHERAL VASCULAR DISEASE Original Studies Renal Sympathetic Denervation as Second-Line Therapy in Mild Resistant Hypertension: A Pilot Study

  2013cited by this paper
• Treating resistant hypertension: role of renal denervation

  2013influential reference
• Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.

  2012cited by this paper
• Health-Related Quality of Life After Renal Denervation in Patients With Treatment-Resistant Hypertension

  2012cited by this paper
• Interventionelle renale Sympathikusdenervation zur Behandlung der therapieresistenten Hypertonie

  2011cited by this paper
• Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension: A Pilot Study

  2011cited by this paper
• Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: Durability of Blood Pressure Reduction Out to 24 Months

  2011cited by this paper
• Interventionelle renale Sympathikusdenervation zur Behandlung der therapieresistenten Hypertonie Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment

  2011cited by this paper
• Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

  2010influential reference
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper

• No citing papers are available for this paper.